Literature DB >> 2985408

Benzodiazepine receptor photoaffinity labeling: correlation of function with binding.

T T Gibbs, C Y Chan, C M Czajkowski, D H Farb.   

Abstract

Exhaustive photoaffinity coupling of flunitrazepam to living spinal cord neurons reduced the capacity of benzodiazepines to potentiate the electrophysiologically measured GABA response. In qualitative agreement with reversible binding data the dose-response curve for enhancement of the GABA response by benzodiazepines was shifted to the right, indicating that the remaining reversible benzodiazepine binding sites have lower affinity for benzodiazepines. Photoaffinity labeling did not reduce inhibition of the GABA response by beta-carbolines and there was only a small decrease in beta-carboline binding. In both control and photoaffinity-labeled cultures, the inhibitory effect of beta-carbolines on the GABA response was reversed in the presence of excess benzodiazepine. The results indicate that the effects of photoaffinity labeling are confined to the BZD recognition site, and that coupling between benzodiazepine receptors and GABA receptors remains intact.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985408     DOI: 10.1016/0014-2999(85)90209-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

Review 1.  Molecular and cellular mechanisms of GABA/benzodiazepine-receptor regulation: electrophysiological and biochemical studies.

Authors:  M Farrant; T T Gibbs; D H Farb
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

2.  Docking of 1,4-benzodiazepines in the alpha1/gamma2 GABA(A) receptor modulator site.

Authors:  D Berezhnoy; T T Gibbs; D H Farb
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

3.  A critical residue in the α1M2-M3 linker regulating mammalian GABAA receptor pore gating by diazepam.

Authors:  Joseph W Nors; Shipra Gupta; Marcel P Goldschen-Ohm
Journal:  Elife       Date:  2021-02-16       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.